跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拜新同 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Nifedipine Controlled-release Tablets
Approved
化学药品
Nifedipine Controlled-release Tablets
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
Aug 5, 2022
Approval ID
8Iee1EjXbli
Company
BAYER AG
Type
化学药品
Approval Details
Approval Id
8Iee1EjXbli
Approval Number
国药准字HJ20171341
Generic Name
硝苯地平控释片
Generic Name En
Nifedipine Controlled-release Tablets
Trade Name
拜新同
Brand Name
拜新同
Drug Type
化学药品
Dosage Form
片剂
Strength
30mg
Reg Date
2022-08-05
Expired Date
2027-08-04
Company Name
BAYER AG
Production Company Name
BAYER AG
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/bayer-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 5, 2022
Approval ID
8Iee1EjXbli
Type
化学药品
Back to NMPA Approvals